• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    FDA Grants Orphan Drug Status to LBL-024 for Neuroendocrine Cancer

    PR NEWSWIRE

    Aditum Bio & Leads Biolabs Form Oblenio Bio for Autoimmune Disorder

    PR NEWSWIRE

    Leads Biolabs Gets FDA Orphan Drug Status for LBL-034 in Myeloma

    PR NEWSWIRE

    Leads Biolabs Unveils Preclinical Data On LBL-047 At EULAR 2024 Congress

    PR NEWSWIRE

    Leads Biolabs` LBL-024 Shows Outstanding Phase II Anti-PD-L1/4-1BB Results

    PR NEWSWIRE

    Leads Gets Nod For Bispecific Antibody LBL-024 Pivotal Trial

    PR NEWSWIRE

    The U.S. FDA Approved the Ph I/II Clinical Trial Application to Evaluate LBL-033

    PR NEWSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.